tiprankstipranks
Sunho Biologics,Inc. (HK:2898)
:2898
Hong Kong Market

Sunho Biologics,Inc. (2898) Financial Statements

0 Followers

Sunho Biologics,Inc. Financial Overview

Sunho Biologics,Inc.'s market cap is currently HK$970.43M. The company's EPS TTM is HK$; its P/E ratio is -4.74; Sunho Biologics,Inc. is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 38.00K¥ 17.53M¥ 1.73M¥ 3.22M
Gross Profit¥ 38.00K¥ 138.00K¥ 473.00K¥ 3.22M
Operating Income¥ -101.36M¥ -66.21M¥ -56.88M¥ -66.62M
EBITDA¥ -94.95M¥ -123.37M¥ -38.11M¥ -64.21M
Net Income¥ -79.97M¥ -132.70M¥ -51.99M¥ -70.63M
Balance Sheet
Cash & Short-Term Investments¥ 457.28M¥ 210.07M¥ 1.82M¥ 10.66M
Total Assets¥ 560.74M¥ 290.45M¥ 70.86M¥ 84.95M
Total Debt¥ 41.20M¥ 9.07M¥ 11.03M¥ 160.86M
Net Debt¥ -37.80M¥ -116.00M¥ -1.82M¥ 147.74M
Total Liabilities¥ 48.80M¥ 394.56M¥ 72.36M¥ 216.50M
Stockholders' Equity¥ 511.94M¥ -104.11M¥ -1.50M¥ -131.55M
Cash Flow
Free Cash Flow¥ -158.28M¥ -41.68M¥ -36.02M¥ -58.17M
Operating Cash Flow¥ -109.02M¥ -40.65M¥ -34.59M¥ -52.65M
Investing Cash Flow¥ -345.04M¥ -83.89M¥ -1.36M¥ -10.36M
Financing Cash Flow¥ 406.53M¥ 255.50M¥ 27.10M¥ 64.98M
Currency in CNY

Sunho Biologics,Inc. Earnings and Revenue History

Sunho Biologics,Inc. Debt to Assets

Sunho Biologics,Inc. Cash Flow

Sunho Biologics,Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.